KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2025)

Elanco Animal Health's Non-Current Assets history spans 9 years, with the latest figure at $9.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 5.33% year-over-year to $9.9 billion; the TTM value through Dec 2025 reached $25.8 billion, up 115.54%, while the annual FY2025 figure was $9.9 billion, 5.33% up from the prior year.
  • Non-Current Assets for Q4 2025 was $9.9 billion at Elanco Animal Health, down from $10.1 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $13.6 billion in Q1 2021 and bottomed at -$4.0 billion in Q2 2024.
  • The 5-year median for Non-Current Assets is $11.4 billion (2022), against an average of $9.3 billion.
  • The largest annual shift saw Non-Current Assets crashed 133.03% in 2024 before it soared 398.81% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $13.2 billion in 2021, then decreased by 7.51% to $12.2 billion in 2022, then dropped by 10.29% to $11.0 billion in 2023, then fell by 14.2% to $9.4 billion in 2024, then rose by 5.33% to $9.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Non-Current Assets are $9.9 billion (Q4 2025), $10.1 billion (Q3 2025), and -$3.6 billion (Q2 2025).